Signaling through MyD88 regulates leukocyte recruitment after brain injury

Journal of Immunology

Volumn 181, Issue 9, 2008, Pages 6481-6490

  Babcock, Alicia A ^a   Toft Hansen, Henrik ^b   Owens, Trevor ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; MYD88 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INJURY; C57BL 6 MOUSE; CONTROLLED STUDY; DENERVATION; ENTORHINAL CORTEX; FLOW CYTOMETRY; GENE EXPRESSION; HIPPOCAMPUS; INFLAMMATION; KINETICS; LEUKOCYTE; LEUKOCYTE MOTILITY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA ISOLATION; SIGNAL TRANSDUCTION; STAB WOUND; T LYMPHOCYTE; TISSUE INJURY; ANIMAL; C3H MOUSE; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; POINT MUTATION; STEREOTACTIC PROCEDURE; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; DENERVATION; ENTORHINAL CORTEX; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; MACROPHAGES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; POINT MUTATION; SIGNAL TRANSDUCTION; STEREOTAXIC TECHNIQUES; T-LYMPHOCYTE SUBSETS;

EID: 58749112026     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.9.6481     Document Type: Article

References (80)

1. Schwartz, M. 2003. Macrophages and microglia in central nervous system injury: are they helpful or harmful? J. Cereb. Blood Flow Metab. 23: 385-394. (Pubitemid 36403019)
2. Jones, T. B., E. E. McDaniel, and P. G. Popovich. 2005. Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr. Pharm. Des. 11: 1223-1236. (Pubitemid 40458268)
3. Jones, K. J., C. J. Serpe, S. C. Byram, C. A. Deboy, and V. M. Sanders. 2005. Role of the immune system in the maintenance of mouse facial motoneuron viability after nerve injury. Brain Behav. Immun. 19: 12-19.
4. Owens, T., A. A. Babcock, J. M. Millward, and H. Toft-Hansen. 2005. Cytokine and chemokine inter-regulation in the inflamed or injured CNS. Brain Res. Brain Res. Rev. 48: 178-184. (Pubitemid 40585748)
5. Streit, W. J., R. E. Mrak, and W. S. Griffin. 2004. Microglia and neuroinflammation: a pathological perspective. J. Neuroinflammation 1: 14.
6. Hauwel, M., E. Furon, C. Canova, M. Griffiths, J. Neal, and P. Gasque. 2005. Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res. Brain Res. Rev. 48: 220-233.
7. Nguyen, M. D., J. P. Julien, and S. Rivest. 2002. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev. Neurosci. 3: 216-227. (Pubitemid 135706591)
8. Ghirnikar, R. S., Y. L. Lee, and L. F. Eng. 1998. Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem Res. 23: 329-340. (Pubitemid 28109878)
9. Ransohoff, R. M., and M. Tani. 1998. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation? Trends Neurosci. 21: 154-159.
10. Stoll, G., S. Jander, and M. Schroeter. 2002. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv. Exp. Med. Biol. 513: 87-113. (Pubitemid 36332404)
11. Bsibsi, M., R. Ravid, D. Gveric, and J. M. van Noort. 2002. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61: 1013-1021. (Pubitemid 35278723)
12. Jack, C. S., N. Arbour, J. Manusow, V. Montgrain, M. Blain, E. McCrea, A. Shapiro, and J. P. Antel. 2005. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 175: 4320-4330.
13. Kielian, T., P. Mayes, and M. Kielian. 2002. Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression. J. Neuroimmunol. 130: 86-99. (Pubitemid 35239996)
14. Mishra, B. B., P. K. Mishra, and J. M. Teale. 2006. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J. Neuroimmunol. 181: 46-56.
15. Babcock, A. A., M. Wirenfeldt, T. Holm, H. H. Nielsen, L. Dissing-Olesen, H. Toft-Hansen, J. M. Millward, R. Landmann, S. Rivest, B. Finsen, and T. Owens. 2006. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J. Neurosci. 26: 12826-12837.
16. Ziegler, G., D. Harhausen, C. Schepers, O. Hoffmann, C. Rohr, V. Prinz, J. Konig, H. Lehrach, W. Nietfeld, and G. Trendelenburg. 2007. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem. Biophys. Res. Commun. 359: 574-579. (Pubitemid 46898990)
17. Lehnardt, S., S. Lehmann, D. Kaul, K. Tschimmel, O. Hoffmann, S. Cho, C. Krueger, R. Nitsch, A. Meisel, and J. R. Weber. 2007. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J. Neuroimmunol. 190: 28-33. (Pubitemid 47625604)
18. Tang, S. C., T. V. Arumugam, X. Xu, A. Cheng, M. R. Mughal, D. G. Jo, J. D. Lathia, D. A. Siler, S. Chigurupati, X. Ouyang, et al. 2007. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. USA 104: 13798-13803.
19. Caso, J. R., J. M. Pradillo, O. Hurtado, P. Lorenzo, M. A. Moro, and I. Lizasoain. 2007. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 115: 1599-1608. (Pubitemid 46648645)
20. Park, C., I. H. Cho, D. Kim, E. K. Jo, S. Y. Choi, S. B. Oh, K. Park, J. S. Kim, and S. J. Lee. 2008. Toll-like receptor 2 contributes to glial cell activation and heme oxygenase-1 expression in traumatic brain injury. Neurosci. Lett. 431: 123-128.
21. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364.
22. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
23. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296: 301-305. (Pubitemid 34303674)
24. Rifkin, I. R., E. A. Leadbetter, L. Busconi, G. Viglianti, and A. Marshak-Rothstein. 2005. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol. Rev. 204: 27-42. (Pubitemid 40460491)
25. Kielian, T. 2006. Toll-like receptors in central nervous system glial inflammation and homeostasis. J. Neurosci. Res. 83: 711-730.
26. Tanga, F. Y., N. Nutile-McMenemy, and J. A. DeLeo. 2005. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. USA 102: 5856-5861.
27. Hua, F., J. Ma, T. Ha, Y. Xia, J. Kelley, D. L. Williams, R. L. Kao, I. William Browder, J. B. Schweitzer, J. H. Kalbfleisch, and C. Li. 2007. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J. Neuroimmunol. 190: 101-111.
28. Nguyen, M. D., J. P. Julien, and S. Rivest. 2001. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1β in neurodegeneration. Ann. Neurol. 50: 630-639.
29. Turrin, N. P., and S. Rivest. 2004. Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol. Dis. 16: 321-334.
30. Kigerl, K. A., W. Lai, S. Rivest, R. P. Hart, A. R. Satoskar, and P. G. Popovich. 2007. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 102: 37-50.
31. Simard, A. R., D. Soulet, G. Gowing, J. P. Julien, and S. Rivest. 2006. Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49: 489-502.
32. Simard, A. R., and S. Rivest. 2007. Neuroprotective effects of resident microglia following acute brain injury. J. Comp. Neurol. 504: 716-729. (Pubitemid 350246584)
33. Kang, J., and S. Rivest. 2007. MyD88-deficient bone marrow cells accelerate onset and reduce survival in a mouse model of amyotrophic lateral sclerosis. J. Cell Biol. 179: 1219-1230. (Pubitemid 350277740)
34. Kim, D., M. A. Kim, I. H. Cho, M. S. Kim, S. Lee, E. K. Jo, S. Y. Choi, K. Park, J. S. Kim, S. Akira, et al. 2007. A critical role of Toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J. Biol. Chem. 282: 14975-14983. (Pubitemid 47093373)
35. Tahara, K., H. D. Kim, J. J. Jin, J. A. Maxwell, L. Li, and K. Fukuchi. 2006. Role of Toll-like receptor signalling in Aβ uptake and clearance. Brain 129: 3006-3019. (Pubitemid 44684521)
36. Richard, K. L., M. Filali, P. Prefontaine, and S. Rivest. 2008. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid β1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J. Neurosci. 28: 5784-5793.
37. Boivin, A., I. Pineau, B. Barrette, M. Filali, N. Vallieres, S. Rivest, and S. Lacroix. 2007. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J. Neurosci. 27: 12565-12576. (Pubitemid 350127805)
38. Cao, C. X., Q. W. Yang, F. L. Lv, J. Cui, H. B. Fu, and J. Z. Wang. 2007. Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem. Biophys. Res. Commun. 353: 509-514. (Pubitemid 46023466)
39. Koedel, U., U. M. Merbt, C. Schmidt, B. Angele, B. Popp, H. Wagner, H. W. Pfister, and C. J. Kirschning. 2007. Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses. Am. J. Pathol. 171: 200-213. (Pubitemid 47339239)
40. Zhou, H., B. M. Lapointe, S. R. Clark, L. Zbytnuik, and P. Kubes. 2006. A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. J. Immunol. 177: 8103-8110. (Pubitemid 44846329)
41. Prinz, M., F. Garbe, H. Schmidt, A. Mildner, I. Gutcher, K. Wolter, M. Piesche, R. Schroers, E. Weiss, C. J. Kirschning, et al. 2006. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116: 456-464. (Pubitemid 43228363)
42. Kielian, T., N. K. Phulwani, N. Esen, M. M. Syed, A. C. Haney, K. McCastlain, and J. Johnson. 2007. MyD88-dependent signals are essential for the host immune response in experimental brain abscess. J. Immunol. 178: 4528-4537. (Pubitemid 46492405)
43. Babcock, A. A., W. A. Kuziel, S. Rivest, and T. Owens. 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 23: 7922-7930.
44. Wirenfeldt, M., A. A. Babcock, R. Ladeby, K. L. Lambertsen, F. Dagnaes-Hansen, R. G. Leslie, T. Owens, and B. Finsen. 2005. Reactive microgliosis engages distinct responses by microglial subpopulations after minor central nervous system injury. J. Neurosci. Res. 82: 507-514. (Pubitemid 41579350)
45. Jensen, M. B., I. V. Hegelund, N. D. Lomholt, B. Finsen, and T. Owens. 2000. IFN-γ enhances microglial reactions to hippocampal axonal degeneration. J. Neurosci. 20: 3612-3621.
46. Jensen, M. B., B. Finsen, and J. Zimmer. 1997. Morphological and immunophenotypic microglial changes in the denervated fascia dentata of adult rats: correlation with blood-brain barrier damage and astroglial reactions. Exp. Neurol. 143: 103-116.
47. Fagan, A. M., and F. H. Gage. 1994. Mechanisms of sprouting in the adult central nervous system: cellular responses in areas of terminal degeneration and reinnervation in the rat hippocampus. Neuroscience 58: 705-725.
48. Werts, C., R. I. Tapping, J. C. Mathison, T. H. Chuang, V. Kravchenko, I. Saint Girons, D. A. Haake, P. J. Godowski, F. Hayashi, A. Ozinsky, et al. 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2: 346-352. (Pubitemid 33706346)
49. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150. (Pubitemid 28361303)
50. Pfeffer, K., T. Matsuyama, T. M. Kundig, A. Wakeham, K. Kishihara, A. Shahinian, K. Wiegmann, P. S. Ohashi, M. Kronke, and T. W. Mak. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467. (Pubitemid 23143346)
51. Lu, B., B. J. Rutledge, L. Gu, J. Fiorillo, N. W. Lukacs, S. L. Kunkel, R. North, C. Gerard, and B. J. Rollins. 1998. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187: 601-608. (Pubitemid 28093362)
52. Glaccum, M. B., K. L. Stocking, K. Charrier, J. L. Smith, C. R. Willis, C. Maliszewski, D. J. Livingston, J. J. Peschon, and P. J. Morrissey. 1997. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159: 3364-3371.
53. Hoshino, K., H. Tsutsui, T. Kawai, K. Takeda, K. Nakanishi, Y. Takeda, and S. Akira. 1999. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J. Immunol. 162: 5041-5044. (Pubitemid 29307100)
54. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088. (Pubitemid 29001265)
55. Kuziel, W. A., S. J. Morgan, T. C. Dawson, S. Griffin, O. Smithies, K. Ley, and N. Maeda. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA 94: 12053-12058.
56. Toft-Hansen, H., A. A. Babcock, J. M. Millward, and T. Owens. 2007. Down-regulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system J. Neuroinflammation 4: 24. (Pubitemid 350111695)
57. Wirenfeldt, M., L. Dissing-Olesen, A. A. Babcock, M. Nielsen, M. Meldgaard, J. Zimmer, I. Azcoitia, R. G. Leslie, F. Dagnaes-Hansen, and B. Finsen. 2007. Population control of resident and immigrant microglia by mitosis and apoptosis. Am. J. Pathol. 171: 617-631. (Pubitemid 47344694)
58. Renno, T., M. Krakowski, C. Piccirillo, J. Y. Lin, and T. Owens. 1995. TNF-α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154: 944-953.
59. Sedgwick, J. D., S. Schwender, H. Imrich, R. Dorries, G. W. Butcher, and V. ter Meulen. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. USA 88: 7438-7442.
60. Remington, L. T., A. A. Babcock, S. P. Zehntner, and T. Owens. 2007. Microglial recruitment, activation, and proliferation in response to primary demyelination. Am. J. Pathol. 170: 1713-1724.
61. Toft-Hansen, H., R. K. Nuttall, D. R. Edwards, and T. Owens. 2004. Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J. Immunol. 173: 5209-5218. (Pubitemid 39387804)
62. Wheeler, R. D., S. P. Zehntner, L. M. Kelly, L. Bourbonniere, and T. Owens. 2006. Elevated interferon γ expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis. Immunology 118: 527-538.
63. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
64. Kariko, K., H. Ni, J. Capodici, M. Lamphier, and D. Weissman. 2004. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279: 12542-12550. (Pubitemid 38445825)
65. Vollmer, J., S. Tluk, C. Schmitz, S. Hamm, M. Jurk, A. Forsbach, S. Akira, K. M. Kelly, W. H. Reeves, S. Bauer, and A. M. Krieg. 2005. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 202: 1575-1585. (Pubitemid 41746603)
66. Boule, M. W., C. Broughton, F. Mackay, S. Akira, A. Marshak-Rothstein, and I. R. Rifkin. 2004. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199: 1631-1640.
67. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
68. Allan, S. M., P. J. Tyrrell, and N. J. Rothwell. 2005. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5: 629-640.
69. Basu, A., J. K. Krady, M. O'Malley, S. D. Styren, S. T. DeKosky, and S. W. Levison. 2002. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J. Neurosci. 22: 6071-6082. (Pubitemid 35387650)
70. Wheeler, R. D., A. C. Culhane, M. D. Hall, S. Pickering-Brown, N. J. Rothwell, and G. N. Luheshi. 2000. Detection of the interleukin 18 family in rat brain by RT-PCR. Brain Res. Mol. Brain Res. 77: 290-293. (Pubitemid 30317358)
71. Menge, T., S. Jander, and G. Stoll. 2001. Induction of the proinflammatory cytokine interleukin-18 by axonal injury. J. Neurosci. Res. 65: 332-339. (Pubitemid 32727035)
72. Jander, S., M. Schroeter, and G. Stoll. 2002. Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response. J. Cereb. Blood Flow Metab. 22: 62-70. (Pubitemid 34038384)
73. Wheeler, R. D., H. Boutin, O. Touzani, G. N. Luheshi, K. Takeda, and N. J. Rothwell. 2003. No role for interleukin-18 in acute murine stroke-induced brain injury. J. Cereb. Blood Flow Metab. 23: 531-535. (Pubitemid 36566129)
74. Sun, D., and A. Ding. 2006. MyD88-mediated stabilization of interferon-γ-induced cytokine and chemokine mRNA. Nat. Immunol. 7: 375-381.
75. Ubogu, E. E., M. K. Callahan, B. H. Tucky, and R. M. Ransohoff. 2006. CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro. Cell. Immunol. 243: 19-29.
76. Rostworowski, M., V. Balasingam, S. Chabot, T. Owens, and V. W. Yong. 1997. Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-γ. J. Neurosci. 17: 3664-3674. (Pubitemid 27200593)
77. Jones, T. B., D. P. Ankeny, Z. Guan, V. McGaughy, L. C. Fisher, D. M. Basso, and P. G. Popovich. 2004. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J. Neurosci. 24: 3752-3761.
78. Eriksson, U., R. Ricci, L. Hunziker, M. O. Kurrer, G. Y. Oudit, T. H. Watts, I. Sonderegger, K. Bachmaier, M. Kopf, and J. M. Penninger. 2003. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9: 1484-1490. (Pubitemid 38004775)
79. Pasare, C., and R. Medzhitov. 2003. Toll-like receptors: balancing host resistance with immune tolerance. Curr. Opin. Immunol. 15: 677-682. (Pubitemid 37441304)
80. Lang, K. S., M. Recher, T. Junt, A. A. Navarini, N. L. Harris, S. Freigang, B. Odermatt, C. Conrad, L. M. Ittner, S. Bauer, et al. 2005. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11: 138-145.